Zostavax : a subcutaneous vaccine for the prevention of herpes zoster.
about
The varicella-zoster virus portal protein is essential for cleavage and packaging of viral DNA.Immunogenicity of novel mumps vaccine candidates generated by genetic modification.Comparative preclinical evaluation of AS01 versus other Adjuvant Systems in a candidate herpes zoster glycoprotein E subunit vaccine.[Protection from a dormant time bomb: The development of effective vaccines against herpes zoster].
P2860
Zostavax : a subcutaneous vaccine for the prevention of herpes zoster.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Zostavax : a subcutaneous vaccine for the prevention of herpes zoster.
@en
Zostavax : a subcutaneous vaccine for the prevention of herpes zoster.
@nl
type
label
Zostavax : a subcutaneous vaccine for the prevention of herpes zoster.
@en
Zostavax : a subcutaneous vaccine for the prevention of herpes zoster.
@nl
prefLabel
Zostavax : a subcutaneous vaccine for the prevention of herpes zoster.
@en
Zostavax : a subcutaneous vaccine for the prevention of herpes zoster.
@nl
P2093
P2860
P1476
Zostavax : a subcutaneous vaccine for the prevention of herpes zoster.
@en
P2093
Bothland Ung
Farhan Khan
Hung Q Doan
Marigdalia K Ramirez-Fort
Stephen K Tyring
P2860
P304
P356
10.1517/14712598.2013.830101
P407
P577
2013-08-29T00:00:00Z